These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 8312551)
1. [The mechanism of the inhibiting effect of a Yersinia pestis protein factor on the hormone-stimulated response of human thrombocytes]. Cherkasova GD; Bochkov VN; Iurkiv VA; Pokrovskiĭ VI Biull Eksp Biol Med; 1993 Nov; 116(11):527-9. PubMed ID: 8312551 [TBL] [Abstract][Full Text] [Related]
2. [Features of regulatory system function in platelets under the effect of plague toxin]. Cherkasova TD; Iurkiv VA Vopr Med Khim; 1994; 40(6):17-20. PubMed ID: 7618291 [TBL] [Abstract][Full Text] [Related]
3. [The capacity of Yersinia pestis toxin to decrease the functional response of human thrombocytes to stimulation by hormones]. Cherkasova TD; Bochkov VN; Iurkiv VA; Pokrovskiĭ VI Biull Eksp Biol Med; 1993 Nov; 116(11):529-32. PubMed ID: 8312552 [TBL] [Abstract][Full Text] [Related]
4. Efflux of cyclic GMP from activated human platelets. Wu XB; Brüne B; Von Appen F; Ullrich V Mol Pharmacol; 1993 Apr; 43(4):564-8. PubMed ID: 8386309 [TBL] [Abstract][Full Text] [Related]
6. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML; Hamm HE J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299 [TBL] [Abstract][Full Text] [Related]
7. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets. Asplund Persson A; Zalavary S; Lindström E; Whiss PA; Bengtsson T; Grenegård M Eur J Pharmacol; 2005 Jul; 517(3):149-57. PubMed ID: 15963495 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation. Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683 [TBL] [Abstract][Full Text] [Related]
9. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473 [TBL] [Abstract][Full Text] [Related]
10. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction. Liao CH; Cheng JT; Teng CM Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Gordge MP; Hothersall JS; Noronha-Dutra AA Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353 [TBL] [Abstract][Full Text] [Related]
12. [The mechanism of the proaggregant action on the thrombocytes of RNA and DNA molecules]. Zakharian RA; Rukhkian LA Nauchnye Doki Vyss Shkoly Biol Nauki; 1990; (2):31-5. PubMed ID: 1693862 [TBL] [Abstract][Full Text] [Related]
13. [Calcium-blocking effect of nitro compounds in human platelets: correlation with changes in the cyclic guanosine monophosphate level]. Men'shikov MIu; Baldenkov GN; Negresku EV; Mazaev AV; Tkachuk VA Biokhimiia; 1987 Mar; 52(3):430-6. PubMed ID: 3034339 [TBL] [Abstract][Full Text] [Related]
14. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663 [TBL] [Abstract][Full Text] [Related]
16. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5. Dunkern TR; Hatzelmann A Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064 [TBL] [Abstract][Full Text] [Related]
17. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558 [TBL] [Abstract][Full Text] [Related]
19. Thrombin-stimulated phospholipase C activity is inhibited without visible delay by a rapid increase in the cyclic GMP levels induced by sodium nitroprusside. Azula FJ; Alzola ES; Conde M; Trueba M; Macarulla JM; Marino A Mol Pharmacol; 1996 Aug; 50(2):367-79. PubMed ID: 8700145 [TBL] [Abstract][Full Text] [Related]
20. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]